Using Continuous Glucose Monitoring to Screen for Diabetes in Cystic Fibrosis Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to improve the screening process for cystic fibrosis-related diabetes (CFRD) by utilizing continuous glucose monitoring (CGM) alongside the standard oral glucose tolerance test (OGTT). Participants will wear Dexcom G7 sensors for 10 days to track glucose levels, while also undergoing annual OGTT and HgbA1c testing. The clinic's registered dietitian will assist with sensor application, data tracking, and dietary education. Data collected will be analyzed to compare CGM results with traditional screening methods to enhance patient care and adherence.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. An adult patient, diagnosed with CF, established with Froedtert Multidisciplinary CF Clinic.
2. Normal glucose tolerance or impaired glucose tolerance per OGTT completed in 2024.
3. At healthy baseline status at time of CGM wear and OGTT.

Exclusion Criteria:

1. Diagnosed with CFRD and treating with diabetogenic medications.
2. s/p transplant
3. pregnancy
4. failure to wear CGM for entirety of 10 days

Where it's running

• The Medical College of Wisconsin
  Milwaukee, Wisconsin, United States Recruiting

Study contacts

• Study coordinator: julie A. Biller, MD
• Email: jbiller@mcw.edu
• Phone: 414-955-7040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating the impact of diet on diabetes risk in cystic fibrosis patients

  This study is testing if a low-added sugar, high-fat diet can lower diabetes risk in adults with cystic fibrosis compared to a standard high-sugar diet.

  Recruiting Emory University · Atlanta, Georgia · NCT05766774

• Effects of a Low Glycemic Load Diet on Diabetes and Body Composition in Adults with Cystic Fibrosis

  This study is testing if a low glycemic load diet can help adults with cystic fibrosis-related diabetes manage their blood sugar and improve their overall health.

  Recruiting at 2 sites Rhode Island Hospital · Boston, Massachusetts and 1 other locations · NCT05723445

• Metformin's effects on lung function in patients with cystic fibrosis-related diabetes

  This study is testing if metformin can help improve lung function in people with cystic fibrosis-related diabetes by giving them different doses of the medication over 14 weeks.

  Recruiting Phase 2 University of Kansas Medical Center · Kansas City, Kansas · NCT04530383

• Inhaled CFTR mRNA for cystic fibrosis in Chinese patients aged 12 and older

  This trial tests inhaled BMD003, a CFTR mRNA therapy, to see if it's safe and shows early signs of benefit in Chinese people 12 years and up with cystic fibrosis.

  Recruiting Early Phase 1 Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07485543

• VX-272 dose escalation in healthy adults

  This will test single and multiple increasing doses of the experimental drug VX-272 in healthy adults to see how safe it is and how the body handles it.

  Recruiting Phase 1 Vertex Pharmaceuticals Incorporated · Tempe, Arizona · NCT07437105

• Prevalence of smoking, passive smoke exposure, and vaping among adults with cystic fibrosis

  This project will see how common smoking, exposure to secondhand smoke, and vaping are among adults with cystic fibrosis followed at the Strasbourg Adult CF Center.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07342920

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.